Image-Guided Hypofractionated Proton Therapy in Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Study.
10/11/2020
/
Publications
/
Hypofractionation
Survival
22 patients with T1 to T2 N0M0 NSCLC received image-guided hypofractionated PBT to a total dose 48 GyRBE in 4 fractions for peripheral lesions and 60 GyRBE in...
Extreme hypofractionated proton radiotherapy for prostate cancer using pencil beam scanning: Dosimetry, acute toxicity and preliminary results.
07/09/2019
/
Publications
/
Hypofractionation
Pencil Beam Scanning - PBS
A study by the research group in Prague. Two hundred patients with early-stage prostate cancer were treated with IMPT on extreme hypofractionated schedule (36...
Post-mastectomy IMPT after immediate breast reconstruction
03/06/2019
/
Publications
/
Hypofractionation
Published in the Green Journal, the Mayo Clinic group reported outcomes of 51 women among who 42 had bilateral reconstruction treated with unilateral IMPT...
Hypofractionated PBT for centrally located lung cancer.
03/05/2019
/
Publications
/
Hypofractionation
This study from Japan reported outcomes of 39 patients who received hypofractionated PBT for centrally located cT1-2N0M0. Twenty-four patients (62%) were...
Initial toxicity, QoL outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated vs. standard fractionated PT for low-risk prostate cancer
08/02/2018
/
Publications
/
Hypofractionation
Quality of life
A multi-center prospective phase 3 randomized trial aimed to identify differences in toxicity and quality-of-life outcomes between standard fractionation and...
Cost effectiveness of prostate cancer radiotherapy.
08/06/2018
/
Publications
/
IMRT
Hypofractionation
This review article by Konski A, examined the data of cost-effectiveness analyses of various radiotherapy modalities including 3DCRT, IMRT, hypofractionated RT...
Acute toxicity of image-guided hypofractionated proton therapy for localized prostate cancer.
11/11/2017
/
Publications
/
Hypofractionation
A study reported toxicity of 526 localized prostate cancer patients treated with proton therapy and demonstrated the safety of HFPT for localized PCa patients...
PTCOG NA Symposium: hypofractionation and SBRT with proton therapy
18/10/2021
/
Event
/
Hypofractionation
New Avenues in Proton Therapy: Hypofractionation, SBRT, and ConformalFLASH®
Proton Image-guided Radiation Assignment for Therapeutic Escalation via Selection of locally advanced head and neck cancer patients [PIRATES]: A Phase I safety and feasibility trial of MRI-guided adaptive particle radiotherapy.
06/11/2021
/
Publications
/
Hypofractionation
Toxicity
IMPT
This a study protocol that details a phase 1 trial investigating a new approach using image-guided proton therapy for dose escalation treatments for selected...
Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis From Breast Cancer.
11/11/2021
/
Publications
/
Hypofractionation
This is a study by the researchers from National Cancer Center, Korea. 17 patients with liver metastasis from breast cancer (LMBC) were treated to a total dose...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.